Literature DB >> 19394788

Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosa.

Marc H Scheetz, John S Esterly, Michael Malczynski, Michael Postelnick, Chao Qi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19394788     DOI： 10.1016/j.diagmicrobio.2009.03.017

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


× No keyword cloud information.
  2 in total

1.  Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification.

Authors:  John S Esterly; Jamie Wagner; Milena M McLaughlin; Michael J Postelnick; Chao Qi; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2012-07-09       Impact factor: 5.191

2.  In vitro activities of doripenem and other carbapenems against clinically important bacteria isolated in intensive care units: nationwide data from the SMART Programme.

Authors:  S-S Jean; P-R Hsueh; W-S Lee; H-T Chang; M-Y Chou; I-S Chen; J-H Wang; C-F Lin; J-M Shyr; W-C Ko; J-J Wu; Y-C Liu; W-K Huang; L-J Teng; C-Y Liu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-01-27       Impact factor: 3.267
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.